Oxford Immunotec Global PLC (OXFD) Director Richard A. Sandberg Sells 3000 Shares

Xavier Trudeau
Juin 5, 2017

In other Oxford Immunotec Global PLC news, VP Elizabeth M. Keiley sold 3,000 shares of the business's stock in a transaction dated Monday, March 20th. RTW Investments LP raised its stake in shares of Oxford Immunotec Global PLC by 130.3% in the fourth quarter. Oxford Immunotec Global PLC (NASDAQ:OXFD) has risen 54.26% since June 2, 2016 and is uptrending. For the week, the stock is performing 5.26%.

Wall Street brokerages forecast that Oxford Immunotec Global PLC (NASDAQ:OXFD) will post earnings of ($0.28) per share for the current fiscal quarter, Zacks Investment Research reports. It has outperformed by 37.56% the S&P500. While the stock price moved along with the volume change, shares are touching $10.12. Goldman Sachs Group Inc. now owns 35,678 shares of the company's stock valued at $553,000 after buying an additional 22,704 shares during the last quarter. Exxon Mobil Corp Com now has $337.61 billion valuation. About 13,446 shares traded.

Since December 5, 2016, it had 0 insider buys, and 10 sales for $1.86 million activity. Following the transaction, the vice president now owns 25,429 shares in the company, valued at $408,135.45. The shares were sold at an average price of $15.43, for a total transaction of $462,900.00. Waddell And Reed Fincl Inc invested in 222,200 shares. Redmile Group Ltd Limited Liability Company reported 2.19% stake. Patten Gp holds 3,270 shares. D E Shaw & Inc accumulated 36,015 shares. Citadel Advisors Limited Liability Co, a Illinois-based fund reported 14,375 shares. (NYSE:CHD) for 395,609 shares. Sumitomo Mitsui Tru holds 854,475 shares. Barclays Public Limited accumulated 117 shares or 0% of the stock. Bnp Paribas Arbitrage Sa has 1,177 shares. Citadel Advsr Ltd Liability Corp holds 14,375 shares or 0% of its portfolio. 17,006 are held by Rothschild Asset Mgmt Inc. RTW Investments LP now owns 543,287 shares of the company's stock worth $8,122,000 after buying an additional 307,387 shares during the last quarter. Therefore 30% are positive. Church & Dwight had 26 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, April 7, the company rating was maintained by Jefferies. Breaking that down further, it has performed 7.12% for the week, 4.25% for the month, 1.33% over the last quarter, 2.91% for the past half-year and 69.64% for this a year ago. Also, COO Peter Edwardson sold 10,000 shares of Oxford Immunotec Global PLC stock in a transaction dated Monday, May 15th. The stock now has a consensus rating of "Hold" and an average target price of $18.00. SANDBERG RICHARD A sold $46,420 worth of stock. The rating was initiated by Sterne Agee CRT on Tuesday, July 21 with "Neutral". Finally, ValuEngine upgraded shares of Oxford Immunotec Global PLC from a "sell" rating to a "hold" rating in a research report on Friday.

Investors sentiment decreased to 1.54 in Q4 2016. Its down 1.61, from 3.15 in 2016Q3. It is negative, as 1 investors sold OXFD shares while 23 reduced holdings. 9 funds opened positions while 28 raised stakes. Neuberger Berman Group Lc holds 0% or 55,100 shares in its portfolio. Voya Inv Mgmt Ltd owns 11,500 shares or 0% of their United States portfolio. Schwab Charles Inv has 40,500 shares for 0% of their portfolio. Fosun Ltd has invested 0.94% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). Kornitzer Capital Ks invested 0.02% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). Citigroup has 33,463 shares.

Oxford Immunotec Global PLC (NASDAQ:OXFD) last issued its earnings results on Tuesday, May 2nd. 70,306 are owned by Financial Bank Of New York Mellon. Oxford Immunotec Global PLC had a negative net margin of 30.17% and a negative return on equity of 28.36%. Blackrock Inc holds 0% or 2,185 shares. On average, analysts predict that Oxford Immunotec Global PLC will post ($1.09) earnings per share for the current year. Schwab Charles Mngmt Incorporated invested 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). The company reported ($0.36) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.01.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL